EE9400346A - Galaniini antagonist, selle valmistamise protsess ja teda sisaldavad ravimpreparaadid - Google Patents

Galaniini antagonist, selle valmistamise protsess ja teda sisaldavad ravimpreparaadid

Info

Publication number
EE9400346A
EE9400346A EE9400346A EE9400346A EE9400346A EE 9400346 A EE9400346 A EE 9400346A EE 9400346 A EE9400346 A EE 9400346A EE 9400346 A EE9400346 A EE 9400346A EE 9400346 A EE9400346 A EE 9400346A
Authority
EE
Estonia
Prior art keywords
galanin
pro
preparation process
pharmaceutical preparations
preparations containing
Prior art date
Application number
EE9400346A
Other languages
English (en)
Estonian (et)
Inventor
Bartfai Tamas
H�kfelt Tomas
Langel Ulo
Ahren Bo
Lindskog Stefan
Consolo Silvana
Land Tiit
Wiesenfeld-Hallin Zsuzsanna
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9400346A publication Critical patent/EE9400346A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
EE9400346A 1991-05-15 1994-11-03 Galaniini antagonist, selle valmistamise protsess ja teda sisaldavad ravimpreparaadid EE9400346A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101472A SE9101472D0 (sv) 1991-05-15 1991-05-15 Galanin antagonist

Publications (1)

Publication Number Publication Date
EE9400346A true EE9400346A (et) 1996-04-15

Family

ID=20382742

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400346A EE9400346A (et) 1991-05-15 1994-11-03 Galaniini antagonist, selle valmistamise protsess ja teda sisaldavad ravimpreparaadid

Country Status (24)

Country Link
EP (2) EP0514361A1 (de)
JP (1) JPH06507629A (de)
KR (1) KR100221769B1 (de)
AT (1) ATE149525T1 (de)
AU (1) AU664180B2 (de)
CA (1) CA2109503A1 (de)
CZ (1) CZ242293A3 (de)
DE (2) DE69217937T2 (de)
DK (1) DK0585300T3 (de)
EE (1) EE9400346A (de)
ES (1) ES2098510T3 (de)
FI (1) FI935010A7 (de)
GR (1) GR3023150T3 (de)
HU (1) HUT65810A (de)
IE (1) IE921555A1 (de)
IS (1) IS3866A (de)
NO (1) NO934098D0 (de)
PL (1) PL171497B1 (de)
SE (1) SE9101472D0 (de)
SG (1) SG43921A1 (de)
SI (1) SI9200081B (de)
SK (1) SK127793A3 (de)
WO (1) WO1992020709A1 (de)
YU (1) YU50592A (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107400A0 (en) * 1992-11-10 1994-01-25 Cortech Inc Bradykinin antagonists
FR2716205B1 (fr) * 1994-02-17 1996-04-12 Rhone Poulenc Rorer Sa Récepteur galanine, acides nucléiques, cellules transformées et utilisations.
US5972624A (en) * 1996-01-24 1999-10-26 Synaptic Pharmaceutical Corporation Method of identifying ligands which bind recombinant galanin receptor (GALR2)
AU730137B2 (en) 1996-01-24 2001-03-01 H. Lundbeck A/S DNA encoding galanin GALR2 receptors and uses thereof
AU3630297A (en) 1996-07-24 1998-02-10 University Of Bristol, The Galanin
US6329197B2 (en) 1996-10-09 2001-12-11 Synaptic Pharmaceutical Corporation DNA encoding galanin GALR3 receptors and uses thereof
AU741546B2 (en) * 1997-07-24 2001-12-06 Perseptive Biosystems, Inc. Conjugates of transporter peptides and nucleic acid analogs, and their use
EP1065214B1 (de) 1998-03-25 2005-05-04 Takeda Pharmaceutical Company Limited Neue, physiologisch aktive peptide und ihre verwendung.
AU782636B2 (en) * 1999-05-21 2005-08-18 Ortho-Mcneil Pharmaceutical, Inc. 1,4-dithiin and 1,4-dithiepin- 1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor
US6407136B1 (en) 1999-05-21 2002-06-18 Ortho-Mcneil Pharmaceutical, Inc. 1,4-dithiin and 1,4-dithiepin-1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor
EP1089439A1 (de) * 1999-09-28 2001-04-04 TELEFONAKTIEBOLAGET L M ERICSSON (publ) Verschachteler und Eingangsdatabitverschachtelungsverfahren unter Anwendung von symbolkodierter Speicherung und zusätzlichen Informationen
US7220775B2 (en) 2002-08-07 2007-05-22 H. Lundbeck A/S Compound useful for the treatment of neuropathic pain
JP2008517930A (ja) 2004-10-21 2008-05-29 トランス テック ファーマ，インコーポレイテッド ＧａｌＲ１のアゴニストとしてのビススルホンアミド化合物、組成物、及び使用法
GB0523550D0 (en) 2005-11-18 2005-12-28 Hunter Fleming Ltd Therapeutic uses of steroidal compounds
EP2913056A1 (de) * 2006-01-05 2015-09-02 The University of Utah Research Foundation Verfahren und Zusammensetzungen in Zusammenhang mit der Verbesserung von Eigenschaften pharmakologischer Wirkstoffe für das Nervensystem
JP2012501977A (ja) * 2008-09-09 2012-01-26 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 治療剤としてのペプチドの使用
JP2014501248A (ja) 2010-12-15 2014-01-20 ニューロアジュヴァンツ，インコーポレイテッド ニューロペプチド類似体、組成物、及び疼痛の治療方法
US10450343B2 (en) 2013-03-21 2019-10-22 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products
CA2907454C (en) 2013-03-21 2021-05-04 Sanofi-Aventis Deutschland Gmbh Synthesis of hydantoin containing peptide products
CN110055340B (zh) * 2019-04-11 2021-01-01 中国农业大学 一种食品中牛源成分快速检测方法及试剂盒

Also Published As

Publication number Publication date
IE921555A1 (en) 1992-11-18
SG43921A1 (en) 1997-11-14
DK0585300T3 (da) 1997-09-01
HUT65810A (en) 1994-07-28
EP0585300A1 (de) 1994-03-09
NO934098L (no) 1993-11-12
ATE149525T1 (de) 1997-03-15
EP0514361A1 (de) 1992-11-19
YU50592A (sh) 1994-09-09
AU1785892A (en) 1992-12-30
FI935010A0 (fi) 1993-11-12
ES2098510T3 (es) 1997-05-01
SK127793A3 (en) 1994-04-06
CZ242293A3 (en) 1994-07-13
DE69217937D1 (de) 1997-04-10
AU664180B2 (en) 1995-11-09
SI9200081B (sl) 2000-08-31
GR3023150T3 (en) 1997-07-30
DE69217937T2 (de) 1997-06-19
FI935010L (fi) 1993-11-12
SI9200081A (en) 1992-12-31
IS3866A (is) 1992-11-16
JPH06507629A (ja) 1994-09-01
EP0585300B1 (de) 1997-03-05
PL171497B1 (pl) 1997-05-30
WO1992020709A1 (en) 1992-11-26
FI935010A7 (fi) 1993-11-12
NO934098D0 (no) 1993-11-12
CA2109503A1 (en) 1992-11-16
DE585300T1 (de) 1994-06-16
SE9101472D0 (sv) 1991-05-15
KR100221769B1 (ko) 1999-10-01

Similar Documents

Publication Publication Date Title
EE9400346A (et) Galaniini antagonist, selle valmistamise protsess ja teda sisaldavad ravimpreparaadid
FI910286A0 (fi) Analoger av humant insulin och preparat innehaollande dessa.
TW349867B (en) Pharmaceutical composition for inducing a cytotoxic T-lymphocyte responses
DE69028671D1 (de) Löslisches extrazellulares Fragment des menschlischen IFN-beta 2/IL-6-Rezeptors, seine Herstellung und diesen Fragment enthaltende pharmazeutische Mischung
GB9416442D0 (en) Therapeutic heterocycles
DE69230670D1 (de) Zusammensetzungen, die eine blutgerinnselpolymermatrix zur verabreichung von osteogenen proteinen enthalten
EP1233013A4 (de) Phenylalaninderivate
NO871574L (no) Fremgangsmaate for fremstilling av terapeutisk aktive peptider.
ATE191719T1 (de) Analoge des calcitonin aus lachs, ihre herstellung und ihre verwendung als medizin und als analytische reagentien
ES2059545T3 (es) Hormonas de glicoproteinas modificadas por mutagenesis dirigida por puntos y metodos de uso de tales hormonas.
ES2157886T3 (es) Composiciones tensioactivas y procedimientos.
SE8800080L (sv) Laekemedelskomposition
NZ235497A (en) Peptides (possibly related to hirudin) and pharmaceutical compositions for reducing blood coagulation
EP0796867A4 (de) Peptide, bronchodilator und den blutstrom verbesserndes mittel
DE59006159D1 (de) Verwendung von macrolactonen als antiallergica.
FI900298A7 (fi) Substituoituja bentso (b) pyraaneja, menetelmiä niiden valmistamiseksi, niiden käyttö sekä näihin yhdisteisiin perustuvia farmaseuttisia valmisteita
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
IT1217177B (it) Palmitoil-fruttosio-1,6-difosfato,suo uso terapeutico e relativi metodi di preparazione
RU93058426A (ru) Антогонист галанина, способ его получения, пептид, фармацевтический состав и способ лечения
ATE119940T1 (de) Gewebs-plasminogen-aktivator-derivat.
IT1216535B (it) O_(1,2_di_0_acetilglicero_3_fosforil)etanolamina, procedimento per la sua preparazione e suo uso terapeutico.
Cohen et al. Recombinant Factor VIII in Hemophilia
IT8819665A0 (it) (1,2_di_0_acetil_glicero_3_fosforil)_colina, procedimento per la sua preparazione e suo uso terapeutico.
NO880831D0 (no) Rekombinant human vevsplasminogen-aktivatorblanding.
GB8903389D0 (en) Accessories for use by motorists and others such as ramblers,walkers and climbers